GRAHAM PETER J 4

What Happened

• Peter J. Graham, Chief Legal Officer of ADC Therapeutics (ADCT), was granted 221,100 restricted stock units (RSUs) on June 30, 2026. The Form 4 reports the acquisition as 221,100 shares at $0.00 (transaction code A — award/grant). RSUs are a contingent right to receive one share each if and when they vest; they are not immediately issued shares and carry no purchase cash outlay now.

Key Details

• Transaction date: 2026-06-30; Form 4 filed 2026-07-02 (appears timely).
• Transaction type/code: Award/Grant (A).
• Amount: 221,100 RSUs; reported acquisition price: $0.00; total reported value on Form 4: $0.
• Shares owned after transaction: not specified in the provided filing excerpt — see the full SEC filing for total beneficial ownership.
• Footnote: RSUs vest upon the earlier of (i) June 30, 2027 or (ii) termination of employment by the issuer without cause or by the reporting person for good reason, and are subject to continued employment on vesting date. Each RSU converts to one share when vested.

Context

• RSU grants are a common form of executive compensation; they do not represent immediate economic value until they vest and convert into shares. They typically carry tax and holding implications at vesting and do not convey voting rights while unvested. This filing documents the grant, not a market purchase or sale.